07/27/2015 - 11:19am

The Food and Drug administration announced Friday that it had approved Praluent (alirocumab), a cholesterol-lowering PCSK9 inhibitor injection. 

07/27/2015 - 11:02am

The FDA has approved Daklinza (daclatasvir), in combination with sofosbuvir, in treatment for chronic hepatitis C virus genotype 3 infections.  

07/24/2015 - 12:39pm

The Food and Drug Administration announced Friday that it had approved Novartis’ Odomzo (sonidegib). The drug is meant to treat basal cell carcinoma, the most common form of advanced skin cancer.

07/24/2015 - 12:33pm

The Food and Drug Administration announced Friday that it approved Technivie (ombitasvir, paritaprevir and ritonavir) for use in combination with ribavirin for the treatment of hepatitis C virus (HCV) genotype 4 infections in patients without scarring and cirrhosis.

07/24/2015 - 12:31pm

On Friday, Stichting Preferred Shares Mylan, an independent foundation established in the Netherlands, announced that it would exercise its full call option to purchase 488,388,431 preferred shares in Mylan.

07/22/2015 - 2:17pm

Novartis will be able to introduce Sandoz’s Zarxio (filgrastim) after Sept. 2, the U.S. Court of Appeal for the Federal Circuit ruled Wednesday. 

07/20/2015 - 11:58am

Access to healthcare drove 82.9% more blood pressure screenings and 26.9% more diabetes screenings.

07/20/2015 - 7:34am

Patients surfing the content on Elsevier's Health Library can search by a specific condition or diagnosis or move through an easy-to-skim, A-to-Z list of healthcare topics.

07/17/2015 - 1:13pm

Amneal Pharmaceuticals has introduced four new products since June.